Amiodarone is a cost-neutral way of preventing atrial fibrillation after surgery for lung cancer.

@article{Riber2014AmiodaroneIA,
  title={Amiodarone is a cost-neutral way of preventing atrial fibrillation after surgery for lung cancer.},
  author={Lars Peter Riber and Thomas Decker Christensen and Hans Kristian Pilegaard},
  journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery},
  year={2014},
  volume={45 1},
  pages={120-5}
}
OBJECTIVES Our aim was to estimate the costs and health benefits of routinely administered postoperative amiodarone as a prophylactic agent in reducing the risk of atrial fibrillation in patients undergoing surgery for lung cancer. METHODS This was a cost-effectiveness study, based on the randomized, controlled, double-blinded PASCART study, using avoidance of atrial fibrillation as the measure of benefit. Two hundred and fifty-four eligible, consecutively enrolled patients, undergoing… CONTINUE READING